Author(s):
Ayat Abbood, Hassan Hadi Ali, Samir Azzat Malik, Dima AlDiab, Nasser Thallaj
Email(s):
profthallaj@gmail.com
DOI:
10.52711/0974-360X.2025.00028
Address:
Ayat Abbood1, Hassan Hadi Ali2, Samir Azzat Malik3, Dima AlDiab4, Nasser Thallaj5*
1Department of Medicinal Chemistry and Quality Control, University of Tishreen, Lattaquia, Syria.
2University of Al Mashreq, College of Engineering Technology, Baghdad, Iraq.
3MSC Pharmaceutical Chemistry, College of Pharmacy, University of Mustaqbal, Babylon, Iraq.
4Department of Food and Anlytical Chemistry, University of Tishreen, Lattaquia, Syria.
5Department of Medicinal Chemistry and Quality Control, University of AL-Rachid, Damascus, Syria.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2025
ABSTRACT:
This research aimed to analyze the charge variant profiles of monoclonal antibodies (mAbs) conjugated to maytansine derivatives or tomaymycin compounds via a non-cleavable linker, utilizing the imaging capillary isoelectric focusing (icIEF) technique. Initially, the charge variant profiles for three mAbs were assessed, revealing both major and minor variants among the samples. Specifically, mAB1 and mAB2 displayed two distinct charge variants with isoelectric points (pI) of 9.00 and 8.95, respectively. In contrast, mAB3 showed a predominant charge variant with a pI of 8.50, along with two minor variants (pI values of 8.30 and 8.60). The conjugation of mAB1 involved a maytansine derivative using non-cleavable linkers, while mAB2 and mAB3 were linked to tomaymycin molecules. The resulting non-cleavable antibody conjugates exhibited greater heterogeneity and acidity than their unconjugated forms. The observed pI ranges were 7.4 to 8.9 for mAB1 conjugates (?pI: 1.4), 8.2 to 8.9 for mAB2 (?pI: 0.7), and 7.4 to 8.4 for mAB3 (?pI: 1). The icIEF method proved effective for tracking the charge profiles of antibody-drug conjugates (ADCs), showing excellent repeatability for both intra-day and inter-day measurements for unconjugated mAbs and ADCs.
Cite this article:
Ayat Abbood, Hassan Hadi Ali, Samir Azzat Malik, Dima AlDiab, Nasser Thallaj. Investigation of the Charge Variant Profile of Non-cleavable Conjugated Antibodies. Research Journal of Pharmacy and Technology. 2025;18(1):185-0. doi: 10.52711/0974-360X.2025.00028
Cite(Electronic):
Ayat Abbood, Hassan Hadi Ali, Samir Azzat Malik, Dima AlDiab, Nasser Thallaj. Investigation of the Charge Variant Profile of Non-cleavable Conjugated Antibodies. Research Journal of Pharmacy and Technology. 2025;18(1):185-0. doi: 10.52711/0974-360X.2025.00028 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-1-28
REFERENCES:
1. Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Antibody–drug conjugates come of age in oncology. Nat Rev Drug Discov. 2023; June; 22: 641–661. https://doi.org/10.1038/s41573-023-00709-2.
2. Gottardi M, Sperotto A, Ghelli Luserna Di Rorà A, Padella A, Cangini D, Giannini MB, et al. Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future. Minerva Med. 2020; Oct; 111(5): 395-410. doi: 10.23736/S0026-4806.20.07019-6.
3. Yang Y, Wang S, Ma P, Jiang Y, Cheng K, Yu Y, et al. Drug conjugate-based anticancer therapy - Current status and perspectives. Cancer Letters. 2023; Jan: 215969. https://doi.org/10.1016/j.canlet.2022.215969.
4. Khongorzul P, Ling CJ, Khan FU, Ihsan AU, Zhang J. Antibody-Drug Conjugates: A Comprehensive Review. Mol Cancer Res. 2020; Jan; 18(1): 3-19. doi: 10.1158/1541-7786.MCR-19-0582.
5. Baah S, Laws M, Rahman KM. Antibody-Drug Conjugates-A Tutorial Review. Molecules. 2021; May; 26(10): 2943. doi: 10.3390/molecules26102943.
6. Su Z, Xiao D, Xie F, Liu L, Wang Y, Fan S, Zhou X, et al. Antibody–drug conjugates: Recent advances in linker chemistry. Acta Pharm Sin B. 2021; Dec; 11(12): 3889-3907. https://doi.org/10.1016/j.apsb.2021.03.042.
7. Salloum R, Baddour F, Abbood A. A Questionnaire to Evaluate Undergraduate Students’ Consumption and Awareness of Non-Steroidal Anti-Inflammatory Drugs in Syria. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR). 2024; 4(4): June 1-6. DOI: 10.54105/ijapsr.C4041.04040624.
8. Zanboua R, Abbood A. Survey of Knowledge About the Interaction Between Food and Drugs Among the Syrian Population. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR), 2024; 4(4): June: 22-28. DOI: 10.54105/ijapsr.D4044.04040624.
9. Mahfouz H, Assaf A, Abbood A. Survey of Usage and Awareness of Ibuprofen Among the Syrian Population. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR). 2024; 4(5): August 23-28. DOI: 10.54105/ijapsr.E4048.04050824.
10. Abbood A. Overview of Analytical Methods for Characterizing the Charge Heterogeneity of Antibody-Drug Conjugates. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR), 2024Volume-4 Issue-5 16-22. DOI: 10.54105/ijapsr.E4047.04050824
11. Beck A, Nowak C, Meshulam D, Reynolds K, Chen D, Pacardo DB, et al. Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants. Antibodies (Basel). 2022; Nov.20; 11(4): 73. doi: 10.3390/antib11040073.
12. Fekete P, Beck A, Veuthey JL, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015; Sep; 113: 43-55. https://doi.org/10.1016/j.jpba.2015.02.037.
13. Matsuda Y, Kliman M, Mendelsohn BA. Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology. J Am Soc Mass Spectrom. 2020; Jul1. doi: 10.1021/jasms.0c00129.
14. Gahoual R, Beck A, Leize-Wagner E, François YN. Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products. J. Chromatogr. B Biomed. Appl. 2016; Oct; 1032: 61-78. https://doi.org/10.1016/j.jchromb.2016.05.028.
15. Chen T, Chen Y, Stella C, Medley CD, Gruenhagen JA, Zhang K. Imaged capillary isoelectric focusing (icIEF) tandem high resolution mass spectrometry for charged heterogeneity of protein drugs in biopharmaceutical discovery. J Pharm Biomed Anal. 2016; Oct; 1032: 39-50. https://doi.org/10.1016/j.jchromb.2016.07.023.
16. Abbood A, Herrenknecht C, Proczek G, Descroix S, Rodrigo J, Taverna M, Smadja C. Hexylacrylate-based mixed-mode monolith, a stationary phase for the nano-HPLC separation of structurally related enkephalins. Anal Bioanal Chem. 2011; Apr. 400(2): 459-68. doi: 10.1007/s00216-011-4762-4.
17. Wu J, McElroy W, Pawliszyn J, Heger CD. Imaged capillary isoelectric focusing: Applications in the pharmaceutical industry and recent innovations of the technology. TrAC Trends Analyt Chem. 2022; May; 150: 116567. https://doi.org/10.1016/j.trac.2022.116567.
18. Cao S, Dong YH, Wang DF, Liu ZP. Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy. Curr Med Chem. 2020; 27(27): 4567-4576. doi: 10.2174/0929867327666200316144610.
19. Abbood A. Optimization of the Imaged cIEF Method for Monitoring the Charge Heterogeneity of Antibody-Maytansine Conjugate. J Anal Methods Chem. 2023; 8150143. https://doi.org/10.1155/2023/8150143.
20. Tozuka Z, Yazawa H, Murata M, Takaya T. Studies on tomaymycin. III. Synthesis and antitumor activity of tomaymycin analogs. J Antibiot (Tokyo). 1983; Dec; 36(12): 1699-708. doi: 10.7164/antibiotics.36.1699.
21. Goyon A, Excoffier M, Janin-Bussat MC, Bobaly B, Fekete S, Guillarme D, et al.. Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies. J Chromatogr B. 2017; 1065: 119–128. doi: 10.1016/j.jchromb.2017.09.033.
22. Wagner-Rousset E, Fekete S, Morel-Chevillet L, Colas O, Corvaïa N, Cianférani S, et al. Development of a fast workflow to screen the charge variants of therapeutic antibodies. J. Chromatogr. A. 2017; May: 1498: 147–154. doi: 10.1016/j.chroma.2017.02.065.
23. Spanov B, Govorukhina N, van de Merbel NC, Bischoff R. Analytical tools for the characterization of deamidation in monoclonal antibodies. Journal of Chromatography Open. 2022; Nov; 2: 100025. https://doi.org/10.1016/j.jcoa.2021.100025.
24. Cai B, Pan H, Flynn GC. C-terminal lysine processing of human immunoglobulin G2 heavy chain in vivo. Biotechnol Bioeng. 2011; Feb; 108(2): 404-12. doi: 10.1002/bit.22933.
25. Dennler P, Fischer E, Schibli R. Antibody Conjugates: From Heterogeneous Populations to Defined Reagents. Antibodies. 2015; 4(3): 197-224. https://doi.org/10.3390/antib4030197.
26. Lin J, Lazar AC. Determination of charge heterogeneity and level of unconjugated antibody by imaged cIEF. Methods Mol. Biol. (Clifton, N.J.), 2013; 1045: 295–302. https://doi.org/10.1007/978-1-62703-541-5_19.
27. Isbera M, Abbood A, Ibrahim W. Weight and Content Uniformity of Warfarin Sodium Half Tablets. Research J. Pharm. and Tech. 2016; 9(3): 215-218. doi: 10.5958/0974-360X.2016.00039.1
28. Abbood A, Layka R. Weight and content uniformity Study of captopril half-tablets. Research J. Pharm. and Tech. 2017; 10(6): 1621-1626. doi: 10.5958/0974-360X.2017.00285.2.
29. Chbani D, Abbood A, Alkhayer M. Determination of Nitrite and Nitrate Ions levels in some types of processed meats marketed locally. Research J. Pharm. and Tech. 2018; 11(4): 1442-1447. doi: 10.5958/0974-360X.2018.00269.X.
30. Abbood A, Malek Z, Al-Homsh Y, Thallaj N. In vitro Study for Antibiotic resistance of bacteria causing Urinary Tract Infection from Syrian adults. Research J. Pharm. and Tech. 2022; 15(10): 4727-2. doi: 10.52711/0974-360X.2022.00794.
31. Abbood A, Malek Z, Thallaj N. Antibiotic resistance of urinary tract pathogens in Syrian children. Research J. Pharm. and Tech. 2022; 15(11): 4935-9. doi: 10.52711/0974-360X.2022.00829.
32. Deeb DN, Aldiab D, Sulaeman S. Effect of Storage Conditions on Bacteriological Growth in Infant Cereals. Research J. Pharm. and Tech. 2021; 14(2): 667-672. doi: 10.5958/0974-360X.2021.00119.0.
33. Alsubot S, Aldiab D. 5-hydroxymethylfurfural Levels in Coffee and Study of some effecting factors. Research J. Pharm. and Tech. 2019; 12(9): 4263-4268. doi: 10.5958/0974-360X.2019.00733.9.
34. Asaad RA. Hormone Receptor Status and its Relation to C-Reactive Protein and other Prognostic factors in Breast Cancer in Jableh- Syria. Research J. Pharm. and Tech. 2017; 10(9): 3003-3010. doi: 10.5958/0974-360X.2017.00532.7.
35. Asaad RA, Abdullah SS. Breast Cancer Subtypes (BCSs) Classification according to Hormone Receptor Status: Identification of Patients at High Risk in Jableh- Syria. Research J. Pharm. and Tech. 2018; 11(8): 3703-3710. doi: 10.5958/0974-360X.2018.00680.7.
36. Besherb S, Alallan L, Hassan Agha MA, AIshamas I, Thallaj N. Influence of soil salinity on the chemical composition of essential oil of Rosmarinus Officinalis in Syria, Research J. Pharm. and Tech. 2024; 17(4).
37. Machkour A, Thallaj NK, Benhamou L, Lachkar M, Mandon D. he Coordination Chemistry of FeCl3 and FeCl2 to Bis [2‐(2, 3‐dihydroxyphenyl)‐6‐pyridylmethyl](2‐pyridylmethyl) amine: Access to a Diiron (iii) Compound with an Unusual Pentagonal‐Bipyramidal/Square‐Pyramidal EnvironmentChemistry–A European Journal. 2006: 25; 12(25): 6660-6668. https://doi.org/10.1002/chem.200600276.
38. Labban L, Thallaj N, Malek Z. The implications of E-cigarettes or" vaping" on the nutritional status. Journal of Medical Research and Health Sciences, 2019; 2(11): 784-787. https://doi.org/10.15520/jmrhs.v2i11.128.
39. Labban L, Thallaj N, labban A. Assessing the Level of Awareness and Knowledge of COVID 19 Pandemic among Syrians. Archives of Medicine, 2020; 12, 2:8, 1-5. DOI: 10.36648/1989-5216.12.2.309.
40. Thallaj NK, Przybilla J, Welter R, Mandon D. A ferrous center as reaction site for hydration of a nitrile group into a carboxamide in mild conditions. J. Am. Chem. Soc. 2008; 130: 2414-2415. https://doi.org/10.1021/ja710560g.
41. Thallaj N. Microwave-Assisted Synthesis of Oxadiazole and Thiazolidine Derivatives. Indian Journal of Advanced Chemistry, 1, 3, 2022. 10-14. DOI:10.54105/ijac.d2015.102222.
42. Thallaj N. Quick Review of Chemistry Related to the [Fe]- Hydrogenases. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR) 2022; 2(4): 1-15. DOI:10.54105/ijapsr.C4016.062422.
43. Thallaj N. A Short Review of Some Examples of the Binding of Fullerenes C60 to Transition Metal Complexes. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR) 2022. 2,6, 1-12. DOI: 10.54105/ijapsr.C4015.102622.
44. Thallaj N. Review of a Few Selected Examples of Intermolecular Dioxygenases Involving Molecular Oxygen and Non-Heme Iron Proteins. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR) 2023. 3, 2, 1-18. DOI:10.54105/ijapsr.C4011.023223.
45. Thallaj N. A Brief Overview of the General Characteristics and Reactivity Towards Dioxygen of the Ferrous Tris (2-Pyridylmethyl Amine) Series Complexes is Presented. International Journal of Advanced Pharmaceutical Sciences and Research (IJAPSR) 2023. 3, 3, 1-18. DOI:10.54105/ijapsr.C4012.043323.
46. Thallaj N. Detecting Antioxidant Behavior for Phenolic Content of Some Beauty Care Creams in Syrian Market. Indian Journal of Advanced Chemistry. 2024; 2(1): 10–14, Jan., doi: 10.54105/ijac.C2013.041322.
47. Thallaj NK, Mandon D, White KA. The Design of Metal Chelates with a Biologically Related Redox‐Active Part: Conjugation of Riboflavin to Bis (2‐pyridylmethyl) amine Ligand and Preparation of a Ferric Complex Eur. J. of Inorg. Chem., 2007: 44–47. https://doi.org/10.1002/ejic.200600789.
48. Wane A, Thallaj NK, Mandon D. The Reactivity of Molecular Dioxygen on a Series of Isostructural Dichloroferrous Complexes with Tripodal Tetraamine Ligands: General Access to µ-oxo Diferric Complexes, and Effect of α-Fluorination on the Kinetics of the Reaction. Chemistry A European Journal 14 (22), 6742-6753. https://doi.org/10.1002/chem.200701967
49. Abbood A, Thallaj N. Comparison between chromatofocusing and icIEF charge variant profiles of unconjugated monoclonal antibodies and their drug conjugates. Arab Journal of Pharmaceutical Sciences. 2023: 7; (1).
50. Thallaj N. Characterization of charge heterogeneity of antibody -drug conjugate by anion-exchange chromatofocusing. Tishreen University Journal-Medical Sciences Series. 2023; 44 (6):21-29.